• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肝衰竭患者出血和侵入性操作期间凝血功能障碍的管理

Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure.

作者信息

Drolz Andreas, Ferlitsch Arnulf, Fuhrmann Valentin

机构信息

Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

出版信息

Visc Med. 2018 Aug;34(4):254-258. doi: 10.1159/000491106. Epub 2018 Jul 16.

DOI:10.1159/000491106
PMID:30345282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6189540/
Abstract

Alterations in hemostasis are a characteristic feature of advanced liver disease. Patients with coagulopathy of advanced liver disease are prone to bleedings and also thromboembolic events. Under stable conditions, cirrhosis patients show alterations in both pro- and anticoagulatory pathways, frequently resulting in a rebalanced hemostasis. This review summarizes current recommendations of management during bleeding and prior to invasive procedures in patients with cirrhosis.

摘要

止血功能的改变是晚期肝病的一个特征性表现。晚期肝病合并凝血功能障碍的患者容易发生出血以及血栓栓塞事件。在病情稳定的情况下，肝硬化患者的促凝和抗凝途径均出现改变，常导致止血功能重新平衡。本文综述了肝硬化患者出血时及侵入性操作前的当前管理建议。

相似文献

1
Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure.肝衰竭患者出血和侵入性操作期间凝血功能障碍的管理
Visc Med. 2018 Aug;34(4):254-258. doi: 10.1159/000491106. Epub 2018 Jul 16.
2
Algorithms for managing coagulation disorders in liver disease.肝病凝血障碍的管理算法。
Hepatol Int. 2018 Sep;12(5):390-401. doi: 10.1007/s12072-018-9886-6. Epub 2018 Jul 31.
3
Endoscopy in the coagulopathic patient.凝血功能障碍患者的内镜检查。
Curr Opin Gastroenterol. 2019 Sep;35(5):401-407. doi: 10.1097/MOG.0000000000000559.
4
Hemostasis in patients with liver disease.肝病患者的止血。
Acta Gastroenterol Belg. 2009 Oct-Dec;72(4):433-40.
5
[Bleeding and thrombosis – acute complications of liver cirrhosis].[出血与血栓形成——肝硬化的急性并发症]
Lakartidningen. 2016 Mar 15;113:DUHD.
6
AGA Clinical Practice Update: Coagulation in Cirrhosis.AGA 临床实践更新：肝硬化中的凝血。
Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. Epub 2019 Apr 12.
7
Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis.肝硬化患者凝血功能障碍与侵入性操作后出血风险的相关性
Saudi J Gastroenterol. 2018 Jul-Aug;24(4):220-227. doi: 10.4103/sjg.SJG_486_17.
8
Bleeding Risk with Invasive Procedures in Patients with Cirrhosis and Coagulopathy.肝硬化和凝血功能障碍患者侵入性操作的出血风险
Curr Gastroenterol Rep. 2017 Sep;19(9):45. doi: 10.1007/s11894-017-0585-6.
9
Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic children.对失代偿期肝硬化儿童上消化道出血风险评估的新见解。
Pediatr Transplant. 2019 Jun;23(4):e13390. doi: 10.1111/petr.13390. Epub 2019 Mar 19.
10
Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most?肝硬化中的自发性出血或血栓形成：最应担心的是什么？
World J Hepatol. 2015 Jul 18;7(14):1818-27. doi: 10.4254/wjh.v7.i14.1818.

引用本文的文献

1
Development and validation of machine learning models to predict esophagogastric variceal rebleeding risk in HBV-related cirrhosis after endoscopic treatment: a prospective multicenter study.预测内镜治疗后乙肝相关肝硬化患者食管胃静脉曲张再出血风险的机器学习模型的开发与验证：一项前瞻性多中心研究
EClinicalMedicine. 2025 Aug 20;87:103436. doi: 10.1016/j.eclinm.2025.103436. eCollection 2025 Sep.
2
Major Bleeding in the Emergency Department: A Practical Guide for Optimal Management.急诊科的严重出血：最佳管理实用指南
J Clin Med. 2025 Jan 25;14(3):784. doi: 10.3390/jcm14030784.
3
[Bleeding in liver diseases].[肝脏疾病中的出血]
Med Klin Intensivmed Notfmed. 2024 Sep;119(6):458-464. doi: 10.1007/s00063-024-01167-3. Epub 2024 Aug 13.
4
Albumin‑bilirubin grade and INR for the prediction of esophagogastric variceal rebleeding after endoscopic treatment in cirrhosis.白蛋白-胆红素分级和国际标准化比值用于预测肝硬化内镜治疗后食管胃静脉曲张再出血
Exp Ther Med. 2023 Sep 11;26(5):501. doi: 10.3892/etm.2023.12200. eCollection 2023 Nov.
5
Approach to thromboelastography-based transfusion in cirrhosis: An alternative perspective on coagulation disorders.基于血栓弹力图的肝硬化输血方法：凝血障碍的另一种视角。
World J Gastroenterol. 2023 Mar 7;29(9):1460-1474. doi: 10.3748/wjg.v29.i9.1460.
6
The Risk of Endoscopy-Related Bleeding in Patients with Liver Cirrhosis: A Retrospective Study.肝硬化患者内镜相关出血风险：一项回顾性研究。
Medicina (Kaunas). 2023 Jan 14;59(1):170. doi: 10.3390/medicina59010170.
7
Survival prediction using the Freiburg index of post-TIPS survival (FIPS) in critically ill patients with acute- on chronic liver failure: A retrospective observational study.使用弗赖堡经颈静脉肝内门体分流术后生存指数（FIPS）对急性慢性肝衰竭重症患者进行生存预测：一项回顾性观察研究。
Front Med (Lausanne). 2022 Dec 22;9:1042674. doi: 10.3389/fmed.2022.1042674. eCollection 2022.
8
[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].[急诊与重症医学中急性失代偿期肝硬化的管理]
Anaesthesist. 2022 May;71(5):403-412. doi: 10.1007/s00101-022-01113-y. Epub 2022 Mar 31.
9
Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study.维生素 K 在纠正因肝脏疾病导致的危重患者 INR 升高中的应用适宜性：一项观察性研究。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211050923. doi: 10.1177/10760296211050923.
10
[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].[急诊与重症医学中急性失代偿期肝硬化的管理]
Med Klin Intensivmed Notfmed. 2022 Feb;117(1):73-82. doi: 10.1007/s00063-021-00876-3. Epub 2021 Oct 12.

本文引用的文献

1
[S2k Guideline Gastrointestinal Bleeding - Guideline of the German Society of Gastroenterology DGVS].[S2k 胃肠道出血指南 - 德国胃肠病学会（DGVS）指南]
Z Gastroenterol. 2017 Sep;55(9):883-936. doi: 10.1055/s-0043-116856. Epub 2017 Sep 12.
2
Declining mortality in critically ill patients with cirrhosis in Australia and New Zealand between 2000 and 2015.2000 年至 2015 年期间澳大利亚和新西兰肝硬化重症患者死亡率下降。
J Hepatol. 2017 Dec;67(6):1185-1193. doi: 10.1016/j.jhep.2017.07.024. Epub 2017 Aug 9.
3
Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.肝硬化门静脉高压出血：风险分层、诊断及管理：美国肝病研究协会2016年实践指南
Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1.
4
Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease.终末期肝病凝血障碍的监测与治疗
Visc Med. 2016 Aug;32(4):241-248. doi: 10.1159/000446304. Epub 2016 Aug 4.
5
Treatment of Patients with Cirrhosis.肝硬化患者的治疗
N Engl J Med. 2016 Aug 25;375(8):767-77. doi: 10.1056/NEJMra1504367.
6
Coagulation parameters and major bleeding in critically ill patients with cirrhosis.肝硬化危重症患者的凝血参数与大出血。
Hepatology. 2016 Aug;64(2):556-68. doi: 10.1002/hep.28628. Epub 2016 Jun 9.
7
Management of the critically ill patient with cirrhosis: A multidisciplinary perspective.肝硬化重症患者的管理：多学科视角
J Hepatol. 2016 Mar;64(3):717-35. doi: 10.1016/j.jhep.2015.10.019. Epub 2015 Oct 28.
8
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial.经肝硬变严重凝血障碍患者侵入性操作前血栓弹力描记术指导的血制品应用：一项随机对照试验。
Hepatology. 2016 Feb;63(2):566-73. doi: 10.1002/hep.28148. Epub 2015 Dec 9.
9
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.门静脉高压领域共识的拓展：巴韦诺VI共识研讨会报告：门静脉高压风险分层与个体化治疗
J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3.
10
Point-of-care haemostasis monitoring during liver transplantation reduces transfusion requirements and improves patient outcome.肝移植期间的床旁止血监测可减少输血需求并改善患者预后。
Clin Chim Acta. 2015 Jun 15;446:277-83. doi: 10.1016/j.cca.2015.04.022. Epub 2015 Apr 25.